Someone apparently labeled this group of stocks under the category of "Medical Health Diagnostics." This is stupid and here's why. You are looking at a commercial battery maker, a personal insurance agency, and an automotive chip designer. The only thing they have in common with healthcare is that they are all trying to resuscitate their valuations and survive the ruthless mid-cap arena of 2026.

I have seen this corporate metamorphosis playbook play out far too many times. Rather than quietly grinding away at their core operations, management teams in today's unpredictable market rely on the holy trinity of survival: shuffling executives, raising whatever loose change they can find, and aggressively pivoting to Artificial Intelligence. It is like watching a rerun of the 1999 dot-com bubble where everyone simply appended ".com" to their names. Now, it is the obligatory "AI" slide in the pitch deck. Everyone knows the script is exhausted, but investors still inexplicably buy the ticket.

Let's start with Elong Power (ELPW.US). The company barely clung to its Nasdaq listing earlier this year, with its stock price struggling to find any real footing after a humiliating 80-for-1 reverse split in March. This so-called solid-state battery and energy storage pioneer managed to scrape together a meager USD 6M in a public offering in May 2026. A month later, they tapped Yue as their new Chief Financial Officer. Just a few years ago, anyone with a battery schematic could walk away with hundreds of millions in venture checks. Today? Trying to compete in the cash-incinerating energy storage market—a sector dominated by ruthless behemoths—with a war chest that small? Good luck with that.

Then there is Goosehead Insurance (GSHD.US). It is a traditional, nationwide agency selling home and auto policies. Selling insurance is hardly a sexy Silicon Valley narrative. To be fair, their fundamentals aren't terrible: they posted a solid 23% total revenue growth in Q1 2026, and their stock has outpaced the broader market lately. But apparently, steady growth isn't enough for management. After installing John as CFO in April, they aggressively poached Eben from Hyatt Hotels in June to be their new Chief Technology Officer. His publicized mandate? Expanding the company's "AI-driven capabilities." When a personal insurance broker starts heavily pitching AI, you know we have reached peak buzzword bingo. Why aren't you moving faster on basic underwriting efficiency and lowering customer acquisition costs instead of chasing tech trends?

Finally, we have indie Semiconductor (INDI.US). Of the three, they are the only ones actually building hard tech, specifically vision and radar processors. But since the autonomous driving chip narrative has grown stale, they needed a new hook. Capitalizing on the humanoid robot frenzy, they quickly rolled out a new Edge AI SoC in July 2026. Speculation that their chips are powering FIGURE AI's upcoming robots has sent speculative capital flooding into the stock, driving a recent rally. I will admit it is a smart pivot, but the semiconductor space is unforgiving. The massive in-house silicon efforts from tech giants could crush these peripheral players at any moment.

Bottom line: Whether you are selling solid-state batteries, home insurance, or edge processors, 2026 is all about catching the market's fleeting attention. But when the music finally stops and liquidity dries up, the ones relying on AI buzzwords instead of actual moats are going to get wiped out. It is only a matter of time.

This article does not constitute investment advice.